SignalCorporate
CITIUS PHARMACEUTICALS GAAP EPS OF -$0.34 MISSES BY $0.09, REVENUE OF $1.5M MISSES BY $8.27M - SEEKINGALPHA
EPS miss of $0.09 and revenue shortfall of $8.27M signal significant operational underperformance.
What changed
EPS miss of $0.09 and revenue shortfall of $8.27M signal significant operational underperformance.
Why it matters
EPS miss of $0.09 and revenue shortfall of $8.27M signal significant operational underperformance. — impact context not separately stored; see What changed.
← Dashboard
Aug 17, 2026 05:43 AM ET